The company’s management will webcast a corresponding conference call beginning at
About
With its corporate headquarters in
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
Source:
2024 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.69 USD | +0.75% | +8.03% | -10.03% |
Apr. 30 | Transcript : Nautilus Biotechnology, Inc., Q1 2024 Earnings Call, Apr 30, 2024 | |
Apr. 30 | Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
The company’s management will webcast a corresponding conference call beginning at
About
With its corporate headquarters in
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
Source:
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-10.03% | 337M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |